Gresko E, Ritterhoff S, Sevilla-Perez J, Roscic A, Fröbius K, Kotevic I, Vichalkovski A, Hess D, Hemmings B A, Schmitz M L
Department of Chemistry and Biochemistry, University of Bern, Bern, Switzerland.
Oncogene. 2009 Feb 5;28(5):698-708. doi: 10.1038/onc.2008.420. Epub 2008 Nov 17.
The promyelocytic leukemia (PML) tumor suppressor protein, a central regulator of cell proliferation and apoptosis, is frequently fused to the retinoic acid receptor-alpha (RARalpha) in acute PML. Here we show the interaction of PML with another tumor suppressor protein, the serine/threonine kinase homeodomain-interacting protein kinase (HIPK2). In response to DNA damage, HIPK2 phosphorylates PML at serines 8 and 38. Although HIPK2-mediated phosphorylation of PML occurs early during the DNA damage response, the oncogenic PML-RARalpha fusion protein is phosphorylated with significantly delayed kinetics. DNA damage or HIPK2 expression leads to the stabilization of PML and PML-RARalpha proteins. The N-terminal phosphorylation sites contribute to the DNA damage-induced PML SUMOylation and are required for the ability of PML to cooperate with HIPK2 for the induction of cell death.
早幼粒细胞白血病(PML)肿瘤抑制蛋白是细胞增殖和凋亡的核心调节因子,在急性早幼粒细胞白血病中常与维甲酸受体α(RARα)融合。在此我们展示了PML与另一种肿瘤抑制蛋白——丝氨酸/苏氨酸激酶同源结构域相互作用蛋白激酶(HIPK2)的相互作用。响应DNA损伤时,HIPK2使PML的丝氨酸8和38位点磷酸化。尽管HIPK2介导的PML磷酸化发生在DNA损伤反应的早期,但致癌性PML-RARα融合蛋白的磷酸化动力学明显延迟。DNA损伤或HIPK2表达导致PML和PML-RARα蛋白的稳定。N端磷酸化位点有助于DNA损伤诱导的PML SUMO化,并且是PML与HIPK2协同诱导细胞死亡能力所必需的。